Reata Pharmaceuticals
Why Robinhood?
You can watch RETA and buy or sell other stocks, ETFs, and their options commission-free!About RETA
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
RETA Key Statistics
Stock Snapshot
With a market cap of 6.57B, Reata Pharmaceuticals(RETA) trades at $172.36. The stock has a price-to-earnings ratio of -57.67.
On 2026-03-13, Reata Pharmaceuticals(RETA) stock opened at —, reached a high of —, and a low of —.
The Reata Pharmaceuticals(RETA)'s current trading volume is 0, compared to an average daily volume of 610.38K.
During the past year, Reata Pharmaceuticals(RETA) stock moved between $21.83 at its lowest and $172.46 at its peak.
During the past year, Reata Pharmaceuticals(RETA) stock moved between $21.83 at its lowest and $172.46 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.